# Establishes a fetal and infant mortality review board

**Bill ID:** S6045A
**Session:** 2024
**Sponsor:** Jamaal Bailey
**Status:** In Senate Committee
**PDF:** [S6045A PDF](https://legislation.nysenate.gov/pdf/bills/2024/S6045A)

## Summary

Establishes a fetal and infant mortality review board to study fetal and infant mortality and morbidity and make recommendations on policies, best practices, and strategies to reduce fetal and infant mortality and morbidity within New York city.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  6045
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  March 27, 2023
  ___________
 
 Introduced  by  Sen.  BAILEY -- read twice and ordered printed, and when
  printed to be committed to the Committee on Cities 1
 
 AN ACT to amend the administrative code of the  city  of  New  York,  in
  relation to establishing a fetal infant mortality review board
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. The administrative code of the city of New York is  amended
 by adding a new section 17-166.1 to read as follows:
  ยง  17-166.1  FETAL  INFANT  MORTALITY REVIEW BOARD. A. AS USED IN THIS
 SECTION, UNLESS THE CONTEXT REQUIRES OTHERWISE:
  (1) "REVIEW BOARD" MEANS  THE  FETAL  INFANT  MORTALITY  REVIEW  BOARD
 ESTABLISHED BY THIS SECTION.
  (2)  "FETAL  INFANT  DEATH"  MEANS  FETAL, NEONATAL, AND INFANT DEATHS
 WITHIN ONE YEAR OF BIRTH.
  (3) "SEVERE FETAL INFANT MORBIDITY" OR  "MORBIDITY"  MEANS  UNEXPECTED
 OUTCOMES  OF  PREGNANCY,  LABOR,  OR DELIVERY THAT RESULT IN SIGNIFICANT
 SHORT- OR LONG-TERM CONSEQUENCES TO A CHILD'S HEALTH.
  B. THERE IS HEREBY ESTABLISHED IN  THE  DEPARTMENT  THE  FETAL  INFANT
 MORTALITY  REVIEW BOARD FOR THE PURPOSE OF REVIEWING FETAL INFANT DEATHS
 AND FETAL INFANT MORBIDITY AND DEVELOPING  AND  DISSEMINATING  FINDINGS,
 RECOMMENDATIONS,  AND  BEST PRACTICES TO CONTRIBUTE TO THE PREVENTION OF
 FETAL INFANT MORTALITY AND MORBIDITY. THE REVIEW BOARD SHALL ASSESS  THE
 CAUSE  OF  DEATH,  FACTORS  LEADING TO DEATH AND PREVENTABILITY FOR EACH
 FETAL INFANT DEATH REVIEWED AND, IN THE DISCRETION OF THE REVIEW  BOARD,
 CASES  OF  SEVERE  FETAL INFANT MORBIDITY, AND SHALL DEVELOP AND DISSEM-
 INATE STRATEGIES FOR REDUCING THE RISK OF  FETAL  INFANT  MORTALITY  AND
 MORBIDITY,  INCLUDING  RISK  RESULTING  FROM  RACIAL, ECONOMIC, OR OTHER
 DISPARITIES.  THE COMMISSIONER MAY DELEGATE  THE  AUTHORITY  TO  CONDUCT
 MATERNAL MORTALITY REVIEWS.
  C. (1) THE MEMBERS OF THE REVIEW BOARD SHALL BE COMPRISED OF MULTIDIS-
 CIPLINARY  EXPERTS IN THE FIELD OF FETAL INFANT MORTALITY, FETAL, NEONA-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD10351-01-3
 S. 6045  2
 
 TAL AND INFANT HEALTH AND PUBLIC HEALTH, AND SHALL INCLUDE  HEALTH  CARE
 PROFESSIONALS  OR  OTHER EXPERTS WHO SERVE AND ARE REPRESENTATIVE OF THE
 RACIAL, ETHNIC, AND SOCIOECONOMIC DIVERSITY OF THE CITY OF NEW YORK AND,
 TO  THE  EXTENT POSSIBLE, THE MEDICALLY UNDERSERVED AREAS OF THE CITY OF
 NEW YORK OR AREAS OF THE CITY OF NEW YORK WITH  DISPROPORTIONATELY  HIGH
 OCCURRENCES OF FETAL INFANT MORTALITY OR MORBIDITY.
  (2)  THE  REVIEW  BOARD SHALL BE COMPOSED OF AT LEAST FIFTEEN MEMBERS,
 ALL OF WHOM SHALL BE APPOINTED BY THE COMMISSIONER.
  (3) THE TERMS OF THE REVIEW BOARD MEMBERS SHALL BE  THREE  YEARS.  THE
 COMMISSIONER  MAY CHOOSE TO REAPPOINT REVIEW BOARD MEMBERS TO ADDITIONAL
 THREE-YEAR TERMS.
  (4) A MAJORITY OF THE APPOINTED MEMBERSHIP OF THE REVIEW BOARD, BUT NO
 LESS THAN THREE, SHALL CONSTITUTE A QUORUM.
  (5) WHEN ANY MEMBER OF THE REVIEW BOARD FAILS TO ATTEND THREE  CONSEC-
 UTIVE  REGULAR  MEETINGS,  UNLESS  GOOD CAUSE IS SHOWN FOR SUCH ABSENCE,
 THAT MEMBERSHIP MAY BE DEEMED VACANT FOR PURPOSES OF THE APPOINTMENT  OF
 A SUCCESSOR.
  (6)  MEETINGS  OF THE REVIEW BOARD SHALL BE HELD AT LEAST TWICE A YEAR
 BUT MAY BE HELD MORE FREQUENTLY AS DEEMED NECESSARY, SUBJECT TO  REQUEST
 OF THE DEPARTMENT.
  (7)  MEMBERS  OF  THE  REVIEW BOARD SHALL BE INDEMNIFIED UNDER SECTION
 SEVENTEEN OF THE PUBLIC OFFICERS LAW OR SECTION FIFTY-K OF  THE  GENERAL
 MUNICIPAL LAW, AS THE CASE MAY BE.
  (8)  MEMBERS  OF  THE  REVIEW BOARD SHALL NOT BE COMPENSATED FOR THEIR
 PARTICIPATION ON THE REVIEW BOARD BUT SHALL  RECEIVE  REIMBURSEMENT  FOR
 THEIR ORDINARY AND NECESSARY EXPENSES OF PARTICIPATION.
  (9)  MEMBERSHIP  ON  THE  REVIEW BOARD SHALL NOT DISQUALIFY ANY PERSON
 FROM HOLDING ANY PUBLIC OFFICE OR EMPLOYMENT.
  D. (1) THE COMMISSIONER MAY REQUEST AND  SHALL  RECEIVE  UPON  REQUEST
 FROM  ANY  DEPARTMENT, DIVISION, BOARD, BUREAU, COMMISSION, LOCAL HEALTH
 DEPARTMENT OR OTHER AGENCY OF THE STATE OR POLITICAL SUBDIVISION THEREOF
 OR ANY PUBLIC AUTHORITY, SUCH INFORMATION, INCLUDING BUT NOT LIMITED  TO
 DEATH  RECORDS,  MEDICAL  RECORDS,  AUTOPSY REPORTS, TOXICOLOGY REPORTS,
 HOSPITAL DISCHARGE RECORDS, BIRTH RECORDS AND ANY OTHER INFORMATION THAT
 WILL HELP THE DEPARTMENT UNDER THIS SECTION TO PROPERLY  CARRY  OUT  ITS
 FUNCTIONS,  POWERS  AND  DUTIES.  THE COMMISSIONER MAY REQUEST AND SHALL
 RECEIVE UPON REQUEST FROM ANY DEPARTMENT, DIVISION, BOARD, COMMISSION OR
 OTHER AGENCY UNDER THE AUTHORITY OF THE CITY OF  NEW  YORK  AS  WELL  AS
 HOSPITALS  ESTABLISHED  PURSUANT  TO  ARTICLE TWENTY-EIGHT OF THE PUBLIC
 HEALTH LAW, BIRTHING FACILITIES, MEDICAL EXAMINERS, CORONERS AND CORONER
 PHYSICIANS AND ANY OTHER FACILITY  PROVIDING  SERVICES  ASSOCIATED  WITH
 FETAL  INFANT  MORTALITY  OR  FETAL  INFANT MORBIDITY, SUCH INFORMATION,
 INCLUDING, BUT NOT LIMITED TO, DEATH RECORDS, MEDICAL  RECORDS,  AUTOPSY
 REPORTS,  TOXICOLOGY  REPORTS, HOSPITAL DISCHARGE RECORDS, BIRTH RECORDS
 AND ANY OTHER INFORMATION THAT  WILL  HELP  THE  DEPARTMENT  UNDER  THIS
 SECTION TO PROPERLY CARRY OUT ITS FUNCTIONS, POWERS AND DUTIES.
  (2)  THE COMMISSIONER SHALL RECEIVE AND MAY SOLICIT VOLUNTARY INFORMA-
 TION, INCLUDING ORAL OR WRITTEN STATEMENTS, RELATING TO ANY FETAL INFANT
 DEATH AND CASE OF SEVERE FETAL INFANT MORBIDITY, FROM ANY FAMILY  MEMBER
 OR  OTHER INTERESTED PARTY RELATING TO ANY CASE THAT MAY COME BEFORE THE
 REVIEW BOARD. ORAL STATEMENTS RECEIVED UNDER  THIS  PARAGRAPH  SHALL  BE
 TRANSCRIBED  OR  SUMMARIZED  IN WRITING. THE COMMISSIONER SHALL TRANSMIT
 THAT INFORMATION TO THE REVIEW BOARD CONSIDERING THE CASE.
  (3) BEFORE TRANSMITTING ANY  INFORMATION  TO  THE  REVIEW  BOARD,  THE
 COMMISSIONER  SHALL  REMOVE  ALL PERSONAL IDENTIFYING INFORMATION OF THE
 FETUS OR INFANT, PARENTS OF THE FETUS OR INFANT, HEALTH CARE PRACTITION-
 S. 6045  3
 
 ER OR PRACTITIONERS, OR ANYONE ELSE INDIVIDUALLY NAMED IN SUCH  INFORMA-
 TION,  AS  WELL  AS  THE  HOSPITAL OR FACILITY THAT TREATED THE FETUS OR
 INFANT, AND ANY OTHER INFORMATION SUCH AS GEOGRAPHIC LOCATION  THAT  MAY
 INADVERTENTLY  IDENTIFY  THE  FETUS OR INFANT, FETUS OR INFANT'S FAMILY,
 PRACTITIONER, OR FACILITY. THIS PARAGRAPH SHALL NOT PRECLUDE THE  TRANS-
 MITTING  OF INFORMATION TO THE REVIEW BOARD THAT IS REASONABLY NECESSARY
 TO ENABLE THE REVIEW BOARD TO PERFORM AN APPROPRIATE REVIEW  UNDER  THIS
 SECTION.
  E. THE REVIEW BOARD:
  (1) SHALL COLLECT AND PERFORM CASE REVIEWS OF FETAL AND INFANT DEATHS;
  (2)  SHALL MAKE AND REPORT FINDINGS AND RECOMMENDATIONS TO THE COMMIS-
 SIONER REGARDING THE CAUSE OF  DEATH,  FACTORS  LEADING  TO  DEATH,  AND
 PREVENTABILITY  OF EACH FETAL INFANT DEATH CASE, AND EACH CASE OF SEVERE
 FETAL INFANT MORBIDITY REVIEWED BY THE REVIEW BOARD, BY REVIEWING  RELE-
 VANT  INFORMATION  FOR  EACH CASE IN THE CITY OF NEW YORK AND CONSULTING
 WITH EXPERTS AS NEEDED TO EVALUATE THE INFORMATION FOR EACH DEATH;
  (3) SHALL DEVELOP AND DELIVER TO THE COMMISSIONER RECOMMENDATIONS ON:
  (A) ISSUES OF SEVERE FETAL INFANT MORBIDITY;
  (B) ADDRESSING SOCIAL DETERMINANTS OF FETAL INFANT  HEALTH,  INCLUDING
 RACIAL,  ECONOMIC  OR OTHER HISTORICAL AND CONTEMPORARY INJUSTICES WHICH
 LEAD TO DISPARITIES IN FETAL INFANT OUTCOMES;
  (C) POLICIES, BEST PRACTICES, AND STRATEGIES TO  REDUCE  FETAL  INFANT
 MORTALITY AND MORBIDITY;
  (D) METHODS OF IMPROVING SERVICES AND RESOURCES; AND
  (E)  METHODS  OF  IMPLEMENTING CONTINUOUS QUALITY IMPROVEMENT IN FETAL
 INFANT MORTALITY AND MORBIDITY;
  (4) SHALL ISSUE AN ANNUAL PUBLIC REPORT ON ITS FINDINGS AND  RECOMMEN-
 DATIONS AND MAY ALSO ISSUE PUBLIC REPORTS MORE FREQUENTLY;
  (5)  SHALL  IMPLEMENT  NEEDS  ASSESSMENT, QUALITY ASSURANCE AND POLICY
 DEVELOPMENT AT THE LOCAL LEVEL, WHICH ARE  ESSENTIAL  TO  PUBLIC  HEALTH
 FUNCTIONS;
  (6)  SHALL IDENTIFY AND ADDRESS SYSTEMIC COMMUNITY CONDITIONS CONTRIB-
 UTING TO FETAL INFANT DEATHS;
  (7) SHALL IMPLEMENT A SURVEILLANCE SYSTEM TO MONITOR INCIDENCE, ETIOL-
 OGIES, AND CONTRIBUTING FACTORS AND WHICH CAN DESCRIBE EFFECTS OF HEALTH
 CARE SYSTEM CHANGE;
  (8) SHALL IDENTIFY SYSTEM WIDE CHALLENGES TO  IMPROVING  FETAL  INFANT
 HEALTH CARE;
  (9)  SHALL  ASSESS, PLAN, IMPROVE, AND MONITOR THE SERVICE SYSTEMS AND
 COMMUNITY RESOURCES THAT SUPPORT AND PROMOTE THE HEALTH  AND  WELL-BEING
 OF WOMEN, FETUSES, INFANTS, AND FAMILIES;
  (10)  MAY,  IN ADDITION TO THE FINDINGS AND RECOMMENDATIONS MADE UNDER
 THIS SUBDIVISION, AND CONSISTENT  WITH  ALL  APPLICABLE  CONFIDENTIALITY
 PROTECTIONS, BRING ANY PARTICULAR MATTER TO THE ATTENTION OF THE COMMIS-
 SIONER; AND
  (11)  MAY REQUEST AND SHALL RECEIVE THE ASSISTANCE OF THE COMMISSIONER
 IN CARRYING OUT ITS FUNCTIONS.
  F. THE COMMISSIONER AND THE REVIEW BOARD SHALL EACH KEEP  CONFIDENTIAL
 ANY  INFORMATION  COLLECTED OR RECEIVED UNDER THIS SECTION THAT INCLUDES
 PERSONAL IDENTIFYING INFORMATION OF THE FETUS OR INFANT,  THE  FETUS  OR
 INFANT'S  PARENTS,  HEALTH CARE PRACTITIONER OR PRACTITIONERS, OR ANYONE
 ELSE INDIVIDUALLY NAMED IN SUCH INFORMATION, AS WELL AS THE HOSPITAL  OR
 FACILITY  THAT  TREATED  THE  FETUS OR INFANT, AND ANY OTHER INFORMATION
 SUCH AS GEOGRAPHIC LOCATION THAT MAY INADVERTENTLY IDENTIFY THE FETUS OR
 INFANT, THE FETUS OR INFANT'S PARENTS, PRACTITIONER,  OR  FACILITY,  AND
 SHALL USE THE INFORMATION PROVIDED OR RECEIVED UNDER THIS SECTION SOLELY
 S. 6045  4

 FOR  THE  PURPOSES  OF IMPROVEMENT OF THE QUALITY OF FETAL INFANT HEALTH
 CARE AND TO PREVENT FETAL INFANT MORTALITY AND MORBIDITY. THIS  SUBDIVI-
 SION  SHALL  NOT  PRECLUDE THE TRANSMITTING OF INFORMATION TO THE REVIEW
 BOARD THAT IS REASONABLY NECESSARY TO ENABLE THE REVIEW BOARD TO PERFORM
 AN APPROPRIATE REVIEW UNDER THIS SECTION. ALL RECORDS RECEIVED, MEETINGS
 CONDUCTED, REPORTS, EXCEPT THOSE PUBLIC REPORTS REQUIRED TO BE ISSUED BY
 THE  REVIEW  BOARD  BY THIS SECTION, AND RECORDS MADE AND MAINTAINED AND
 ALL BOOKS AND PAPERS OBTAINED BY THE REVIEW BOARD SHALL BE  CONFIDENTIAL
 AND  SHALL NOT BE MADE OPEN OR AVAILABLE, INCLUDING UNDER ARTICLE SIX OF
 THE PUBLIC OFFICERS LAW, AND SHALL BE LIMITED TO REVIEW BOARD MEMBERS AS
 WELL AS THOSE AUTHORIZED BY THE COMMISSIONER. SUCH INFORMATION SHALL NOT
 BE DISCOVERABLE OR ADMISSIBLE AS EVIDENCE IN ANY ACTION IN ANY COURT  OR
 BEFORE ANY OTHER TRIBUNAL, BOARD, AGENCY OR PERSON.
  G.  THE  COMMISSIONER  MAY USE THE RECOMMENDATIONS AND FINDINGS OF THE
 REVIEW BOARD TO DEVELOP GUIDANCE AND  OTHER  ACTIONS  RELATING  TO  BEST
 PRACTICES,  AND  SHALL DISSEMINATE INFORMATION RELATING TO THAT GUIDANCE
 AND OTHER ACTIONS TO APPROPRIATE HEALTH CARE PROVIDERS.
  ยง 2. This act shall take effect immediately.